Key points are not available for this paper at this time.
The introduction of financial incentives was associated with improvements in the recorded quality of diabetes care in the first year. These improvements included some measures of disease control, but most captured only documentation of recommended aspects of clinical assessment, not patient management or outcomes of care. Improvements in subsequent years were more modest. Variation in care between population groups diminished under the incentives, but remained substantial in some cases.
Kontopantelis et al. (Wed,) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: